HowAppealing

OCTOBER 15, 2021

“Federal Judges or Their Brokers Traded Stocks of Litigants During Cases; Dozens of judges have reported share purchases and sales made while they presided in suits involving those companies, a WSJ investigation found”: Coulter Jones, Joe Palazzolo, and James V. reported nearly a dozen buys and sells of Pfizer Inc.

Litigation 100

Litigation Litigating 100

Law 360

SEPTEMBER 9, 2022

Global Blood Therapeutics Inc. investors have challenged Pfizer's $5.4 billion plan to acquire the sickle cell-drug company, claiming that GBT's top brass made incomplete and misleading disclosures in an attempt to convince shareholders to sign off on the proposed deal.

40

40

FDA Law Blog

MARCH 13, 2024

1.750, applicant is required to submit the following to the USPTO: Evidence that Genmab A/S is expressly authorized to rely upon the regulatory review activities by Genmab US, Inc., According to the PTE application, however, the “Marking Applicant for EPKINL Y® ( epcoritamab-bysp) is Genmab US, Inc., Biogen MA Inc. Lehman , No.

Diligence 59

Diligence Statute Entertainment Government 59

The Crime Report

AUGUST 12, 2021

Some of the governments were offered vaccines from Pfizer Inc. An unidentified government agency was offered 20 million Pfizer-BioNTech doses for $751 million. and partner BioNTech SE, Johnson & Johnson as well as AstraZeneca PLC. Investigators at the U.S. and overseas.

Contract 98

Contract Immigration Government 98